Table 3.

Differences in HRQOL, QALYs, AF symptom severity, and mental health between control and treatment groups.

Outcomes	Beta or Difference	S.E	p-value
Atrial Fibrillation Effect on Quality of Life (AFEQT)
Global	7.3	4.3	0.09
Symptom	3.5	4.9	0.48
Daily activities	7.4	5.8	0.20
Treatment concern	9.6	5.3	0.07
Satisfaction	2.6	5.7	0.65
Short-Form Health Survey (SF-36)
PCS36	1.2	1.3	0.37
MCS36	−0.5	1.4	0.74
EuroQol-5D (EQ-5D)
EQ-5D index	0.0	0.03	0.98
EQ-5D VAS	4.3	2.9	0.13
Quality-adjusted life-years (QALYs)	0.01	0.01	0.24
University of Toronto AF Severity Scale (AFSS)	−0.8	1.5	0.58

Note. Beta or difference = difference in mean score change from baseline to follow-up or difference in mean QALYs from baseline to six months between two arms.

^*p-value < 0.05